Prediction of Gram-Negative Bacteremia in Patients with Cancer and Febrile Neutropenia by Means of Interleukin-8 Levels in Serum: Targeting Empirical Monotherapy versus Combination Therapy
Open Access
- 1 March 2001
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 32 (5), 832-835
- https://doi.org/10.1086/319207
Abstract
In a prospective observational study of 133 neutropenic episodes, interleukin (IL)-8 serum levels >2000 pg/mL at the onset of fever had a sensitivKeywords
This publication has 11 references indexed in Scilit:
- Assessment of Measuring Circulating Levels of Interleukin‐6, Interleukin‐8, C‐Reactive Protein, Soluble Fcy Receptor Type III, and Mannose‐Binding Protein in Febrile Children with Cancer and NeutropeniaClinical Infectious Diseases, 1999
- Diagnostic Value of Procalcitonin Serum Levels in Neutropenic Patients with Fever: Comparison with Interleukin-8Scandinavian Journal of Infectious Diseases, 1999
- Cefepime versus imipenem-cilastatin as empirical monotherapy in 400 febrile patients with short duration neutropenia. CEMIC (Study Group of Infectious Diseases in Cancer).Journal of Antimicrobial Chemotherapy, 1998
- An analysis of interleukin-8, interleukin-6 and C-Reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patientsInfection, 1998
- 1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained FeverClinical Infectious Diseases, 1997
- Open randomized study of cefepime versus piperacillin-gentamicin for treatment of febrile neutropenic cancer patientsAntimicrobial Agents and Chemotherapy, 1997
- Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational studyAntimicrobial Agents and Chemotherapy, 1997
- Early identification of neutropenic patients at risk of gram-positive bacteraemia and the impact of empirical administration of vancomycinEuropean Journal Of Cancer, 1996
- The APACHE III Prognostic SystemChest, 1991
- Ceftazidime Combined with a Short or Long Course of Amikacin for Empirical Therapy of Gram-Negative Bacteremia in Cancer Patients with GranulocytopeniaNew England Journal of Medicine, 1987